Gwen Krivi - Articles and news items

Boehringer Ingelheim logo
Boehringer Ingelheim logo

Lilly reassumes sole worldwide development and commercialization rights for novel basal insulin analog

Industry news, News / 7 January 2013 / Boehringer Ingelheim

Announces it will begin remainder of pre-planned clinical trials for LY2605541…

Lilly Diabetes presents Phase II blood pressure and heart rate data

Industry news, News / 22 May 2012 / Eli Lilly and Company

Phase II trial used ambulatory blood pressure monitoring to evaluate blood pressure and heart rate for dulaglutide…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+